Montreal, October 22, 2010 This week, the last questionnaire was filled out and the final vial of blood was drawn, closing CARTaGENE's first ambitious goal of collecting samples and data from 20 000 Quebecers. With this last recruit, the CARTaGENE Universit of Montral research project has emerged as one the world's most comprehensive and powerful resources for providing an epidemiological snapshot of the health of its participants. This biobank data will be available as a resource to researchers worldwide and will provide greater insight into chronic health conditions such as cardiovascular disease, diabetes and cancer.
"We are extremely pleased that we've met this milestone and are grateful to all the participants who contributed to our project," says Philip Awadalla, CARTaGENE Scientific Director and a professor at the Universit of Montral. "Although there are few biobanks that are larger, ours is the first of its size to collect such extensive data for every participant, which makes it a very valuable scientific resource. In addition the CARTaGENE database is unique in that all the samples were collected the same way and that all the recruits went through the same interviews. This consistency is essential to making it such a precious resource. Data captured from this snapshot of the Quebec population gathered information from participants of many ethnic backgrounds. In addition, the unique French-Canadian population allows scientists to evaluate the impact of genealogies on health. We have already had requests for CARTaGENE data, a testimony to the database's value."
"The success of this first phase is an indicator of society's interest in knowledge," adds Guy Rouleau, Co-Principal Investigator, a Universit de Montral professor, and director of the Sainte-Justine University Hospital Research Center. "This database provides information on many of the principle determinants of health, such as the impact of lifestyle, genetics, environment an
|Contact: Julie Gazaille|
University of Montreal